Affiliation: Boston University
- Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington diseaseSamuel Frank
Boston University School of Medicine, 72 East Concord St, C329, Boston, Massachusetts, USA
Neuropsychiatr Dis Treat 6:657-65. 2010..There are no current treatments to change the course of HD, but education and symptomatic therapies can be effective tools for clinicians to use with patients and families affected by HD...
- Trauma-induced spinal vascular event producing hemipseudoathetosisSamuel Frank
Department of Neurology, Boston University, Boston, Massachusetts 02118, USA
Mov Disord 20:1378-80. 2005..We report on a patient with spinal pseudoathetosis secondary to posterior column vascular incident and physical injury. This unusual case highlights sensory system abnormalities as a cause of movement disorders...
- What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reportsSamuel Frank
Boston University, MA, USA
Neurology 65:1101-3. 2005..Placebo surgeries were generally safe and well tolerated but the number of subjects receiving the procedure was small. Harm occurred more frequently in subjects randomized to the experimental intervention...
- Teaching residents to be teachersSamuel Frank
Boston University School of Medicine, Boston, MA 02118, USA
Nat Clin Pract Neurol 3:236-7. 2007
- Ethics of sham surgery: perspective of patientsSamuel A Frank
Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
Mov Disord 23:63-8. 2008..Future research needs to determine whether eliciting more considered judgments of laypersons would reveal different levels of support for sham surgery...
- A study of chorea after tetrabenazine withdrawal in patients with Huntington diseaseSamuel Frank
Department of Neurology, Boston University School of Medicine, Boston, MA, USA
Clin Neuropharmacol 31:127-33. 2008..To assess tetrabenazine (TBZ) efficacy by evaluating the change in Huntington disease-associated chorea resulting from TBZ treatment withdrawal...
- Advances in the pharmacological management of Huntington's diseaseSamuel Frank
Boston University School of Medicine, Boston, Massachusetts, USA
Drugs 70:561-71. 2010..Although there is no current method to change the course of this devastating disease, education and symptomatic therapies are effective tools available to clinicians and the families affected by HD...
- The neurology resident as teacher: evaluating and improving our roleDavid J Gill
Department of Neurology, University of Rochester, Box 673, 601 Elmwood Ave, Rochester, NY 14642, USA
Neurology 63:1334-8. 2004..There continues to be a need for studies specifically addressing the teaching by neurology residents and fellows...
- The challenges of residents teaching neurologySamuel A Frank
University of Rochester, NY 14620, USA
Neurologist 10:216-20. 2004..Teaching also reinforces knowledge, and residents will likely be better practitioners if some basic skills of teaching are practiced...